USPTO serial 97809055
METSERA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- ELTON, DAVID JONATHAN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with METSERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David Cole
David Cole CADWALADER, WICKERSHAM & TAFT LLP200 LIBERTY STREETNEW YORK, NY 10281United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | House mark for a full line of pharmaceuticals; pharmaceutical preparations for the treatment of metabolic conditions | ACTIVE | — |
| 009 | Downloadable medical software for the automated diagnosis of disease conditions from analysis of medical data | ACTIVE | — |
| 035 | Data collection and analysis of quality metric data services for business purposes in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; business consulting and business analysis services relating to information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications | ACTIVE | — |
| 036 | Providing administration of health care plans, namely, providing insurance verification and prior authorization services for others; financial administration of patient reimbursement programs | ACTIVE | — |
| 042 | Computer programming consultancy; Computer software consulting; Advanced product research in the field of artificial intelligence; Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare access to a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeys, pathways, and care programs; computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, lab data, care demographics, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; Scientific and technological services, namely scientific research and analysis, in the fields of medicine, health and wellness; design and development of computer hardware and computer software; biomedical research; computer software development; scientific laboratory services; provision of information relating to medical and scientific research in the field of pharmaceutical products; computer software programming for others; all of the foregoing services provided in the fields of medicine, health, fitness, exercise and wellness | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Population Health Partners, L.P.
- Other trademarks owned by Population Health Partners, L.P.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Similar marks named METSERA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 6, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 6, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 4, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 2, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 1, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 29, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 29, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 29, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 29, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 29, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 21, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 14, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 27, 2023 | NWAP | NEW APPLICATION ENTERED | — |